DENALI THERAPEUTICS INC (DNLI) Stock Balance Sheet
NASDAQ:DNLI • US24823R1059
Current stock price
18.6 USD
-1.46 (-7.28%)
At close:
18.95 USD
+0.35 (+1.88%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 205.33M | 174.96M | 127.11M | 218.00M | 293.50M | |||
| Marketable Securities | 662.55M | 657.37M | 907.40M | 1.12B | 571.90M | |||
| Receivables | 2.18M | N/A | N/A | 0.00 | 1.20M | |||
| Other Current Assets | 30.60M | 32.10M | 29.63M | 36.10M | 30.60M | |||
| Total Current Assets | 900.66M | 864.44M | 1.06B | 1.37B | 897.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 119.94M | 125.63M | 71.64M | 74.50M | 69.60M | |||
| Investments And Advances | 98.32M | 359.37M | N/A | 0.00 | 425.40M | |||
| Other Non-Current Assets | 25.94M | 24.74M | 18.14M | 13.40M | 11.90M | |||
| Total Non-Current Assets | 244.20M | 509.74M | 89.78M | 87.90M | 507.00M | |||
| TOTAL ASSETS | 1.14B | 1.37B | 1.15B | 1.46B | 1.40B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 83.00K | 3.73M | N/A | N/A | N/A | |||
| Accrued Expenses | 73.84M | 73.22M | 68.50M | 66.70M | 53.20M | |||
| Accounts Payable | 3.33M | 11.14M | 9.48M | 2.80M | 4.80M | |||
| Other Current Liabilities | 21.10M | 14.13M | 0.00 | 294.40M | 320.30M | |||
| Total Current Liabilities | 98.35M | 102.21M | 77.98M | 363.90M | 378.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 5.53M | 5.62M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 27.21M | 36.67M | 44.98M | 53.90M | 63.60M | |||
| Total Non-Current Liabilities | 32.74M | 42.29M | 44.98M | 53.90M | 63.70M | |||
| TOTAL LIABILITIES | 131.09M | 144.50M | 122.96M | 417.80M | 441.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.05B | -1.54B | -1.12B | -971.00M | -645.00M | |||
| Additional Paid In Capital | 3.06B | 2.76B | 2.14B | 2.02B | 1.61B | |||
| Common Shares | 1.89M | 1.77M | 1.71M | 1.70M | 1.50M | |||
| Other Shareholders' Equity | 682.00K | 2.02M | 643.00K | -6.90M | -2.50M | |||
| Shares Outstanding | 156.18M | 144.22M | 138.39M | 136.00M | 122.30M | |||
| Tangible Book Value per Share | 6.49 | 8.53 | 7.45 | 7.66 | 7.87 | |||
| Total Shareholders' Equity | 1.01B | 1.23B | 1.03B | 1.04B | 962.30M | |||
| TOTAL LIABILITIES AND EQUITY | 1.14B | 1.37B | 1.15B | 1.46B | 1.40B | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.00 | N/A | N/A | N/A | |||
| Current Ratio | 9.16 | 8.46 | 13.65 | 3.77 | 2.37 | |||
| Return On Assets (ROA) | -44.77% | -30.77% | -12.59% | -22.33% | -20.70% | |||
| Return On Equity (ROE) | -50.56% | -34.38% | -14.09% | -31.27% | -30.20% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21